Kiuru A - Search Results

1

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.

Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Sanz EJ, et al. Among authors: kiuru a. Lancet. 2005 Feb 5-11;365(9458):482-7. doi: 10.1016/S0140-6736(05)17865-9. Lancet. 2005. PMID: 15705457

2

Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.

Edwards IR, Star K, Kiuru A. Edwards IR, et al. Among authors: kiuru a. Drug Saf. 2007;30(6):515-25. doi: 10.2165/00002018-200730060-00005. Drug Saf. 2007. PMID: 17536877

3

Assessing the impact of drug safety signals from the WHO database presented in 'SIGNAL': results from a questionnaire of National pharmacovigilance Centres.

Ståhl M, Edwards IR, Bowring G, Kiuru A, Lindquist M. Ståhl M, et al. Among authors: kiuru a. Drug Saf. 2003;26(10):721-7. doi: 10.2165/00002018-200326100-00005. Drug Saf. 2003. PMID: 12862506

4

Microdialysis measurements demonstrate a shift to nonoxidative glucose metabolism in rat pancreatic islets transplanted beneath the renal capsule.

Carlsson PO, Kiuru A, Nordin A, Olsson R, Lin JM, Bergsten P, Hillered L, Andersson A, Jansson L. Carlsson PO, et al. Among authors: kiuru a. Surgery. 2002 Sep;132(3):487-94. doi: 10.1067/msy.2002.126506. Surgery. 2002. PMID: 12324763

5

N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.

Dambrova M, Baumane L, Kiuru A, Kalvinsh I, Wikberg JE. Dambrova M, et al. Among authors: kiuru a. Arch Biochem Biophys. 2000 May 1;377(1):101-8. doi: 10.1006/abbi.2000.1745. Arch Biochem Biophys. 2000. PMID: 10775447

6

Substance P endopeptidase-like activity is altered in various regions of the rat central nervous system during morphine tolerance and withdrawal.

Zhou Q, Karlsson K, Liu Z, Johansson P, Le Grevés M, Kiuru A, Nyberg F. Zhou Q, et al. Among authors: kiuru a. Neuropharmacology. 2001 Aug;41(2):246-53. doi: 10.1016/s0028-3908(01)00055-7. Neuropharmacology. 2001. PMID: 11489461

7

Corrigendum to "Postnatal N-acetylcysteine does not provide neuroprotection in extremely low birth weight infants: A follow-up of a randomized controlled trial" [Early Hum. Dev. 132(2019) 13-17].

Kiuru A, Ahola T, Klenberg L, Tommiska V, Lano A, Kleemola P, Haavisto A, Fellman V. Kiuru A, et al. Early Hum Dev. 2019 Jul;134:12. doi: 10.1016/j.earlhumdev.2019.05.004. Epub 2019 May 14. Early Hum Dev. 2019. PMID: 31100514 No abstract available.

8

Postnatal N‑acetylcysteine does not provide neuroprotection in extremely low birth weight infants: A follow-up of a randomized controlled trial.

Kiuru A, Ahola T, Klenberg L, Tommiska V, Lano A, Kleemola P, Haavisto A, Fellman V. Kiuru A, et al. Early Hum Dev. 2019 May;132:13-17. doi: 10.1016/j.earlhumdev.2019.03.006. Epub 2019 Mar 28. Early Hum Dev. 2019. PMID: 30927687 Clinical Trial. No abstract available.

9

EXPERIENCES IN DEVELOPING A NATIONAL DOSE REGISTER IN FINLAND AND MERGING IT WITH THE OVERALL SUPERVISORY DATA SYSTEM.

Lehtinen M, Alén R, Kiuru A. Lehtinen M, et al. Among authors: kiuru a. Radiat Prot Dosimetry. 2016 Sep;170(1-4):442-5. doi: 10.1093/rpd/ncw125. Epub 2016 May 13. Radiat Prot Dosimetry. 2016. PMID: 27179121

10

INVESTIGATIONS CONDUCTED AMONG FINNISH RADIATION WORKERS IN 2004-13 AND THEIR EFFECT ON THE RECORDED INDIVIDUAL DOSES.

Kiuru A, Lehtinen M, Alén R. Kiuru A, et al. Radiat Prot Dosimetry. 2016 Sep;170(1-4):437-41. doi: 10.1093/rpd/ncw113. Epub 2016 May 5. Radiat Prot Dosimetry. 2016. PMID: 27150514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results